Plasma clearance of polyfructosan and extracellular body fluid distribution in idiopathic dilated cardiomyopathy and after heart transplantation

American Journal of Cardiology

Volumn 85, Issue 7, 2000, Pages 843-848

  Galatius, Søren ^a   Bent Hansen, Lasse ^b   Wroblewski, Henrik ^a   Kastrup, Jens ^a  

^a Heart Center   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; AZATHIOPRINE; CALCIUM ANTAGONIST; CYCLOSPORIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN; FRUCTAN; GLUCOCORTICOID;

ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; EXTRACELLULAR SPACE; FEMALE; HEART RATE; HEART TRANSPLANTATION; HUMAN; KIDNEY CLEARANCE; MALE; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; CAPILLARY PERMEABILITY; CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; EXTRACELLULAR SPACE; FRUCTANS; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; MIDDLE AGED; RECOVERY OF FUNCTION;

EID: 0034176589     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00878-4     Document Type: Article

References (30)

1. Anand I.S., Ferrari R., Kalra G.S., Wahi P.L., Poole-Wilson P.A., Harris P.C. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation. 80:1989;299-305.
2. Galatius-Jensen S., Wroblewski H., Emmeluth C., Bie P., Haunsø S., Kastrup J. Plasma endothelin in congestive heart failure effect of the ACE inhibitor, fosinopril . Cardiovasc Res. 32:1996;1148-1154.
3. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol. 2:1983;755-763.
4. Masters R.G., Davies R.A., Keon W.J., Walley V.M., Koshal A., de Bold A.J. Neuroendocrine response to cardiac transplantation. Can J Cardiol. 9:1993;609-617.
5. Braith R.W., Mills R.M.J., Wilcox C.S., Convertino V.A., Davis G.L., Limacher M.C., Wood C.E. Fluid homeostasis after heart transplantation the role of cardiac denervation . J Heart Lung Transplant. 15:1996;872-880.
6. Convertino V.A., Thompson C.A., Benjamin B.A., Keil L.C., Savin W.M., Gordon E.P., Haskell W.L., Schroeder J.S., Sandler H. Haemodynamic and ADH responses to central blood volume shifts in cardiac-denervated humans. Clin Physiol. 10:1990;55-67.
7. Mahy I.R., Shore A.C., Smith L.D., Tooke J.E. Disturbance of peripheral microvascular function in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Cardiovasc Res. 30:1995;939-944.
8. Hesse B., Parving H.H., Lund-Jacobsen H., Noer I. Transcapillary escape rate of albumin and right atrial pressure in chronic congestive heart failure before and after treatment. Circ Res. 39:1976;358-362.
9. Kruhøffer P. The significance of diffusion and convection for the distribution of solutes in the interstitial space. Acta Physiol Scand. 11:1946;37-47.
10. Bent-Hansen L. Whole body capillary exchange of albumin. Alterations in diabetic microangiopathy (thesis). Dan Med Bull. 44:1997;40-55.
11. Bent-Hansen L. Plasma disappearance and distribution volume of polyfructosan in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res. 25:1994;121-128.
12. Sejrsen P., Paaske W.P., Henriksen O. Capillary permeability of 131I-albumin in skeletal muscle. Microvasc Res. 29:1985;265-281.
13. Dupuis J., Goresky C.A., Rose C.P., Stewart D.J., Cernacek P., Schwab A.J., Simard A. Endothelin-1 myocardial clearance, production, and effect on capillary permeability in vivo. Am J Physiol. 273:1997;H1239-H1245.
14. Mertz D.P. Observations on the renal clearance and the volume of the distribution of polyfructosan-S, a new inulin-like substance. Experimentia. 19:1963;248-249.
15. Rossing N., Jensen H. Metabolic studies of different albumin preparations. Clin Sci. 32:1967;89-99.
16. Nielsen O.M. Extracellular volume, renal clearance and whole body permeability-surface area product in man, measured after single injection of polyfructosan. Scand J Clin Lab Invest. 45:1985;217-222.
17. Ingerslev J. A sensitive ELISA for von Willebrand factor (vWf:Ag). Scand J Clin Lab Invest. 47:1987;143-149.
18. Unruh H.W., Goldberg H.S., Oppenheimer L. Pulmonary interstitial compartments and tissue resistance to fluid flux. J Appl Physiol. 57:1984;1512-1519.
19. Levick J.R., Knight A.D. Interaction of plasma colloid osmotic pressure and joint fluid pressure across the endothelium-synovium layer significance of extravascular resistance . Microvasc Res. 35:1988;109-121.
20. Fahr G., Ershler I. Studies of the factors concerned in edema formation. II. The hydrostatic pressure in the capillaries during edema formation in right heart failure. Am J Med. 1940;798-810.
21. Franciosa J.A., Leddy C.L., Wilen M., Schwartz D.E. Relation between hemodynamic and ventilatory responses in determining exercise capacity in severe congestive heart failure. Am J Cardiol. 53:1984;127-134.
22. Michel C.C. The investigation of capillary permeability in single vessels. Acta Physiol Scand Suppl. 463:1979;67-74.
23. Jacobsen T.N., Kassis E., Amtorp O. Effects of orthostatic stress on peripheral capillary filtration in mild congestive heart failure after healing of myocardial infarction. Am J Cardiol. 72:1993;418-422.
24. Lambert E., Mettauer B., Hoppeler H., Charloux A., Charpentier A., Lonsdorfer J. Structure of skeletal muscle in heart transplant recipients. J Am Coll Cardiol. 28:1996;980-984.
25. Galatius S, Wroblewski H, Sorensen VB, Bie P, Arendrup H, Kastrup J. Calf blood flow during prolonged passive tilt in idiopathic dilated cardiomyopathy and after cardiac transplantation. Am J Physiol 2000;278:H239-H248.
26. Vassalli G., Gallino A. Endothelial dysfunction and accelerated coronary artery disease in cardiac transplant recipients. Microcirculation Working Group, European Society of Cardiology. Eur Heart J. 18:1997;1712-1717.
27. Zelis R., Lee G., Mason D.T. Influence of experimental edema on metabolically determined blood flow. Circ Res. 34:1974;482-490.
28. Shulman H., Striker G., Deeg H.J., Kennedy M., Storb R., Thomas E.D. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation glomerular thromboses and tubular injury . N Engl J Med. 305:1981;1392-1395.
29. Dengler T.J., Tiefenbacher C.P., Braun K., Sack F.U., Zimmermann R., Kubler W. Impaired renal function but not high cyclosporine levels determines increased endothelin plasma levels after heart transplantation. Transplant Proc. 27:1995;1956-1957.
30. Webb D.J., Monge J.C., Rabelink T.J., Yanagisawa M. Endothelin new discoveries and rapid progress in the clinic . Trends Pharmacol Sci. 19:1998;5-8.